Entity Common Stock, Shares Outstanding of NEXIEN BIOPHARMA, INC. from Q4 2014 to Q1 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NEXIEN BIOPHARMA, INC. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q4 2014 to Q1 2025.
  • NEXIEN BIOPHARMA, INC. Entity Common Stock, Shares Outstanding for the quarter ending 13 May 2025 was 70,772,196, a 4.9% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 70,772,196 +3,300,000 +4.9% 13 May 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 70,772,196 18 Nov 2024 10-Q 18 Nov 2024 2025 Q1
Q3 2024 70,772,196 +6,000,000 +9.3% 22 Oct 2024 10-K 22 Oct 2024 2024 FY
Q1 2024 67,472,196 +3,950,000 +6.2% 20 Feb 2024 10-Q 20 Feb 2024 2024 Q2
Q3 2023 64,772,196 +3,500,000 +5.7% 25 Sep 2023 10-K 28 Sep 2023 2023 FY
Q1 2023 63,522,196 +3,000,000 +5% 15 May 2023 10-Q 17 May 2023 2023 Q3
Q4 2022 62,772,196 +2,750,000 +4.6% 06 Feb 2023 10-Q 08 Feb 2023 2023 Q2
Q3 2022 61,272,196 +5,500,000 +9.9% 26 Sep 2022 10-K 28 Sep 2022 2022 FY
Q1 2022 60,522,196 +5,000,000 +9% 12 May 2022 10-Q 12 May 2022 2022 Q3
Q4 2021 60,022,196 +4,091,000 +7.3% 04 Feb 2022 10-Q 08 Feb 2022 2022 Q2
Q3 2021 55,772,196 -9,000 -0.02% 12 Oct 2021 10-K 12 Oct 2021 2021 FY
Q1 2021 55,522,196 +1,538,192 +2.8% 05 May 2021 10-Q 05 May 2021 2021 Q3
Q4 2020 55,931,196 +1,947,192 +3.6% 11 Feb 2021 10-Q 11 Feb 2021 2021 Q2
Q3 2020 55,781,196 +1,797,192 +3.3% 24 Sep 2020 10-K 28 Sep 2020 2020 FY
Q1 2020 53,984,004 +268,008 +0.5% 14 May 2020 10-Q 14 May 2020 2020 Q3
Q4 2019 53,984,004 +268,008 +0.5% 12 Feb 2020 10-Q 12 Feb 2020 2020 Q2
Q3 2019 53,984,004 +9,535,508 +21% 25 Sep 2019 10-K 30 Sep 2019 2019 FY
Q1 2019 53,715,996 +9,943,900 +23% 14 May 2019 10-Q 14 May 2019 2019 Q3
Q4 2018 53,715,996 +8,817,233 +20% 11 Feb 2019 10-Q 14 Feb 2019 2019 Q2
Q3 2018 44,448,496 -55,551,504 -56% 25 Sep 2018 10-K 28 Sep 2018 2018 FY
Q1 2018 43,772,096 +21,061,904 +93% 09 May 2018 10-Q 15 May 2018 2018 Q3
Q4 2017 44,898,763 +22,188,571 +98% 13 Feb 2018 10-Q 14 Feb 2018 2018 Q2
Q3 2017 100,000,000 +77,289,808 +340% 31 Oct 2017 10-Q 03 Nov 2017 2018 Q1
Q2 2017 22,710,192 0 0% 30 Jun 2017 10-K 31 Jul 2017 2017 FY
Q1 2017 22,710,192 0 0% 31 Mar 2017 10-Q 04 May 2017 2017 Q3
Q4 2016 22,710,192 0 0% 31 Dec 2016 10-Q 06 Feb 2017 2017 Q2
Q3 2016 22,710,192 0 0% 30 Sep 2016 10-Q 19 Oct 2016 2017 Q1
Q2 2016 22,710,192 0 0% 30 Jun 2016 10-K 28 Sep 2016 2016 FY
Q1 2016 22,710,192 0 0% 31 Mar 2016 10-Q 13 Apr 2016 2016 Q3
Q4 2015 22,710,192 -9,000 -0.04% 31 Dec 2015 10-Q 04 Feb 2016 2016 Q2
Q3 2015 22,710,192 30 Sep 2015 10-Q 14 Oct 2015 2016 Q1
Q2 2015 22,710,192 30 Jun 2015 10-K 15 Sep 2015 2015 FY
Q1 2015 22,710,192 31 Mar 2015 10-Q 06 May 2015 2015 Q3
Q4 2014 22,719,192 31 Dec 2014 10-Q 13 Feb 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.